Cleared Traditional

K964716 - STA LIATEST CONTROL [N]+[P] KIT

K964716 is an FDA 510(k) clearance for STA LIATEST CONTROL [N]+[P] KIT, manufactured by American Bioproducts Co.. The device is a Class 2 Hematology device with product code GGN cleared through the Traditional 510(k) pathway after a 213-day FDA review.

K964716 · American Bioproducts Co. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1997
Decision
213d
Days
Class 2
Risk

K964716 is an FDA 510(k) clearance for the STA LIATEST CONTROL [N]+[P] KIT. Classified as Plasma, Coagulation Control (product code GGN), Class II - Special Controls.

Submitted by American Bioproducts Co. (Parisppany, US). The FDA issued a Cleared decision on June 26, 1997 after a review of 213 days - an extended review cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5425 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Hematology review framework, consistent with the majority of Class II 510(k) submissions.

View all American Bioproducts Co. devices

FDA 510(k) Submission Details - K964716

510(k) Number K964716 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 25, 1996
Decision Date June 26, 1997
Days to Decision 213 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 113d · This submission: 213d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GGN Device Classification - Class 2, Special Controls

Product Code GGN Plasma, Coagulation Control
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GGN Plasma, Coagulation Control

All 91
Devices cleared under the same product code (GGN) and FDA review panel - the closest regulatory comparables to K964716.
AVOCET SYSTEM LIQUID CONTROL LEVEL 1 AND LEVEL 2
K980982 · Avocet Medical, Inc. · Apr 1998
CRYO CHECK INR VALIDATION SET
K971219 · Precision Biologicals, Inc. · Aug 1997
CRYO CHECK APC RESISTANT PLASMA
K971222 · Precision Biologicals, Inc. · Aug 1997
COAGULATION CONTROL PLASMA(ABNORMAL)LEVEL 0
K971428 · Pacific Hemostasis · Jun 1997
TAS PT-NCTEST CONTROLS
K971748 · Cardiovascular Diagnostics, Inc. · May 1997
LYPHOCHEK COAGULATION CONTROL
K964963 · Bio-Rad · Feb 1997